alpelisib (BYL719)

alpelisib · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for alpelisib (BYL719), covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Managed Access Programs for BYL719, Alpelisib